Expo Theater Presentations

Thursday, September 28, 2023

11:45 AM – 12:45 PM

Acella Pharmaceuticals, LLC

Changing the Paradigm of Hypothyroidism Treatment: Two Researchers’ Perspectives

  • Thanh D. Hoang, DO, FACP, FACE
  • Elizabeth A. McAninch, MD

3:00 PM – 4:00 PM

Horizon

Thyroid Eye Disease (TED): Early Diagnosis, Referral, and Treatment with TEPEZZA

  •  Ioannis Papagiannis, MD

Friday, September 29, 2023

11:30 AM – 12:30 PM

Exelixis
An Exelixis Product for the Clinical Management of Appropriate Patients in Differentiated Thyroid Cancer

  • Bryan McIver, MD, PhD

3:00 PM – 4:00 PM

Sonic

Molecular Fingerprinting of Bethesda III-VI Thyroid Nodules by ThyroSeq Detects Over 100 Unique Profiles: A Roadmap for Optimizing Patient Management

  • Yuri Nikiforov, MD, PhD
  • Masha Livhits, MD, FACS
  • Max Schumm, MD

5:00 PM – 6:00 PM

Bayer

The Clinical Role of VITRAKVI (larotrectinib): Presentation for Thyroid Specialists on NTRK Gene Fusions in Thyroid Cancer

  • Dr. Krzysztof Misiukiewicz

Saturday, September 30, 2023

11:30 AM – 12:30 PM

Loxo@Lilly

Retevmo: Precision Oncology for Patients with RET-Positive Thyroid Cancer

  • Bryan McIver, MD, PhD

1:50 PM – 2:50 PM

Qualisure Diagnostics Inc.

Making Treatment Decisions Using a Novel Genomic Classifier for Papillary Thyroid Cancer

  • Adrian Harvey, MD, MEd, MSc, FRCSC, FAC